Bibliography
- Patel M, Shah T, Amin A. Therapeutic opportunities in colon specific drug delivery systems. Crit Rev Ther Drug Carrier Syst 2007;24:147-202
- Patel M, Amin A. Recent trends in microbially and/or enzymatically driven colon-specific drug delivery systems. Crit Rev Ther Drug Carrier Syst 2011;28:489-552
- Patel MM, Amin AF. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer. Drug Deliv 2011;18:281-93
- American Cancer Society. Available from: www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-key-statistics [Last accessed on 27 March 2014]
- Elyagoby A, Layas N, Wong TW. Colon-specific delivery of 5-fluorouracil from zinc pectinate pellets through in situ intracapsular ethylcellulose-pectin plug formation. J Pharm Sci 2013;102:604-16
- Mohandas KM. Colorectal cancer in India: controversies, enigmas and primary prevention. Indian J Gastroenterol 2011;30:3-6
- Kelloff GJ, Schilsky RL, Alberts DS, et al. Colorectal adenomas: a prototype for the use of surrogate end points in the development of cancer prevention drugs. Clin Cancer Res 2004;10:3908-18
- Levine JS, Ahnen DJ. Clinical practice. Adenomatous polyps of the colon. N Engl J Med 2006;355:2551-7
- Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 2000;95:3053-63
- Schatzkin A, Freedman LS, Dawsey SM, Lanza E. Interpreting precursor studies: what polyp trials tell us about large-bowel cancer. J Natl Cancer Inst 1994;86:1053-7
- Stewart SL, Wike JM, Kato I, et al. A population-based study of colorectal cancer histology in the United States, 1998-2001. Cancer 2006;107(5 Suppl):1128-41
- Colorectal cancer. Available from: www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-028323.pdf [Last accessed 27 March 2014]
- Krishnaiah YS, Khan MA. Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer. Pharm Dev Technol 2012;17:521-40
- Patel MM. Drug delivery: oral colon-specific. In: Swarbrick J, editor. Encyclopedia of pharmaceutical science and technology. 4th edition. Taylor & Francis Group, LLC, UK; 2014. p. 1091-121
- Patel MM, Amin AF. Process, optimization and characterization of mebeverine hydrochloride loaded guar gum microspheres for irritable bowel syndrome. Carbohydr Polym 2011;86:536-45
- Patel MM. Cutting-edge technologies in colon-targeted drug delivery systems. Expert Opin Drug Deliv 2011;8:1247-58
- Jain A, Jain SK, Ganesh N, et al. Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. Nanomedicine 2010;6:179-90
- Zhang L, Zhu W, Yang C, et al. A novel folate-modified self-microemulsifying drug delivery system of curcumin for colon targeting. Int J Nanomedicine 2012;7:151-62
- Ashwanikumar N, Kumar NA, Nair SA, Kumar GV. Methacrylic-based nanogels for the pH-sensitive delivery of 5-fluorouracil in the colon. Int J Nanomedicine 2012;7:5769-79
- Ghorab DM, Amin MM, Khowessah OM, Tadros MI. Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: preparation, characterization and in vivo evaluation in rats. Drug Deliv 2011;18:523-35
- Kulthe SS, Bahekar JK, Godhani CC, et al. Modulated release of 5-fluorouracil from pH-sensitive and colon targeted pellets: an industrially feasible approach. Drug Dev Ind Pharm 2013;39:138-45
- Ahmad MZ, Akhter S, Anwar M, Ahmad FJ. Assam Bora rice starch based biocompatible mucoadhesive microsphere for targeted delivery of 5-fluorouracil in colorectal cancer. Mol Pharm 2012;9:2986-94
- Smitha KT, Anitha A, Furuike T, et al. In vitro evaluation of paclitaxel loaded amorphous chitin nanoparticles for colon cancer drug delivery. Colloids Surf B Biointerfaces 2013;104:245-53
- Sharma M, Malik R, Verma A, et al. Folic acid conjugated guar gum nanoparticles for targeting methotrexate to colon cancer. J Biomed Nanotechnol 2013;9:96-106
- Srivastava R, Kumar D, Pathak K. Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet. Int J Pharm 2012;427:153-62
- Yassin AE, Alsarra IA, Alanazi FK, et al. New targeted-colon delivery system: in vitro and in vivo evaluation using X-ray imaging. J Drug Target 2010;18:59-66
- Sharma R, Rawal RK, Malhotra M, et al. Design, synthesis and ex-vivo release studies of colon-specific polyphosphazene-anticancer drug conjugates. Bioorg Med Chem 2014;22:1104-14
- Dev RK, Bali V, Pathak K. Novel microbially triggered colon specific delivery system of 5-Fluorouracil: statistical optimization, in vitro, in vivo, cytotoxic and stability assessment. Int J Pharm 2011;411:142-51
- Thakral NK, Ray AR, Bar-Shalom D, et al. The quest for targeted delivery in colon cancer: mucoadhesive valdecoxib microspheres. Int J Nanomedicine 2011;6:1057-68
- Zhang L, Cao F, Ding B, et al. Eudragit® S100 coated calcium pectinate microspheres of curcumin for colon targeting. J Microencapsul 2011;28:659-67
- Deol PK, Kaur IP. Improving the therapeutic efficiency of ginger extract for treatment of colon cancer using a suitably designed multiparticulate system. J Drug Target 2013;21:855-65